Evidence for the presence of CB2-1ike cannabinoid receptors on peripheral nerve terminals

European Journal of Pharmacology

Volumn 339, Issue 1, 1997, Pages 53-61

  Griffin, Graeme ^a   Fernando, Susanthi R ^a   Ross, Ruth A ^a   McKay, Neil G ^a   Ashford, Michael L J ^a   Shire, David ^b   Huffman, John W ^c   Yu, Shu ^c   Lainton, Julia A H ^c   Pertwee, Roger G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b SANOFI   (France)

^c CLEMSON UNIVERSITY   (United States)

Author keywords

Cannabinoid CB1 receptors; Cannabinoid CB2 receptors; Cannabinoids; Myenteric plexus longitudinal muscle preparation, guinea pig small intestine; SR141716A; Vas deferens, mouse

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; CANNABINOID RECEPTOR; DRONABINOL; JWH 051; MESSENGER RNA; NALOXONE; NORADRENALIN BITARTRATE; RIMONABANT; UNCLASSIFIED DRUG; YOHIMBINE; DRUG RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; GUINEA PIG; MALE; MOUSE; MUSCLE CONTRACTION; MYENTERIC PLEXUS; NONHUMAN; PERIPHERAL NERVE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR AFFINITY; VAS DEFERENS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECT; ELECTROSTIMULATION; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; METHODOLOGY; MOLECULAR GENETICS; NERVE ENDING; PHYSIOLOGY; SEQUENCE HOMOLOGY; SMALL INTESTINE;

AMINO ACID SEQUENCE; ANIMALS; ELECTRIC STIMULATION; GUINEA PIGS; HUMANS; INTESTINE, SMALL; MALE; MICE; MOLECULAR SEQUENCE DATA; MUSCLE CONTRACTION; MYENTERIC PLEXUS; NERVE ENDINGS; PERIPHERAL NERVES; POLYMERASE CHAIN REACTION; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; VAS DEFERENS;

EID: 0031578457     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01336-8     Document Type: Article

References (28)

1. Colquhoun, D., 1971. Lectures on Biostatistics. Oxford University Press, Oxford.
2. 2 receptors. Mol. Pharmacol. 48:1995;443-450.
3. Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
4. Huffman J.W., Yu S., Showalter V., Abood M.E., Wiley J.L., Compton D.R., Martin B.R., Bramblett R.D., Reggio P.H. Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. J. Med. Chem. 39:1996;3875-3877.
5. 1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol. 118:1996;2023-2028.
6. Kuster J.E., Stevenson J.I., Ward S.J., D'Ambra T.E., Haycock D.A. Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther. 264:1993;1352-1363.
7. Lynn A.B., Herkenham M. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids. J. Pharmacol. Exp. Ther. 268:1994;1612-1623.
8. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
9. McCulloch C.R., Pollock D. Effects of chronic drug treatment on the sensitivity of mouse vas deferens to drugs. Eur. J. Pharmacol. 118:1985;253-261.
10. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
11. Pacheco M., Childers S.R., Arnold R., Casiano F., Ward S.J. Aminoalkylindoles: Actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther. 257:1991;170-183.
12. Paton W.D.M., Zar M.A. The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J. Physiol. 194:1968;13-33.
13. Pertwee R.G., Griffin G. A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens. Eur. J. Pharmacol. 272:1995;67-72.
14. Pertwee R.G., Stevenson L.A., Elrick D.B., Mechoulam R., Corbett A.D. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol. 105:1992;980-984.
15. Pertwee R.G., Stevenson L.A., Griffin G. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP-55,940, WIN-55,212-2 and anandamide. Br. J. Pharmacol. 110:1993;1483-1490.
16. Pertwee R.G., Griffin G., Lainton J.A.H., Huffman J.W. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur. J. Pharmacol. 284:1995;241-247.
17. Pertwee R., Griffin G., Fernando S., Li X., Hill A., Makriyannis A. AM630, a competitive cannabinoid receptor antagonist. Life Sci. 56:1995;1949-1955.
18. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol. 118:1996;2199-2205.
19. 8-tetrahydrocannabinol in two isolated tissue preparations. Eur. J. Pharmacol. 315:1996;195-201.
20. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.-C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
21. Seong Y.H., Baba A., Matsuda T., Iwata H. 5-Hydroxytryptamine modulation of electrically induced twitch responses of mouse vas deferens: Involvement of multiple 5-hydroxytryptamine receptors. J. Pharmacol. Exp. Ther. 254:1990;1012-1016.
22. Showalter V.M., Compton D.R., Martin B.R., Abood M.E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278:1996;989-999.
23. Smith C.F.C., Rowland P.B. Dopamine receptors in the mouse vas deferens. Arch. Int. Pharmacodyn. 299:1989;144-154.
24. Stjärne L., Åstrand P. Relative pre- and postjunctional roles of noradrenaline and adenosine 5′-triphosphate as neurotransmitters of the sympathetic nerves of guinea-pig and mouse vas deferens. Neuroscience. 14:1985;929-946.
25. Stjärne L., Lundberg J.M., Åstrand P. Neuropeptide Y - A cotransmitter with noradrenaline and adenosine 5′-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study. Neuroscience. 18:1986;151-166.
26. Stone T.W. The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and γ-aminobutyric acid. Br. J. Pharmacol. 73:1981;791-796.
27. 2 and receptor differentiation: A statistical analysis of competitive antagonism. Life Sci. 25:1979;637-654.
28. 2 -receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;522-532.